All posts of vasili

New article on cardiovascular medicine

23.11.2016 – Our new article on cardiovascular medicine has been published in BMJ Open. Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland. Published in BMJ Open 2016;6:e012604. Article    

Head office expanded and open positions

5.10.2016 – EPID Research is growing. We recently renewed and expanded our head office in Espoo. Now we are looking for new talented people to join us. We currently have the following positions open: Director – Real-World Evidence, Pharmacoepidemiologist and Study Coordinator.    

EPID Research presented two posters in ESC 2016

1.9.2016 – Ville Kytö presented two posters of a study conducted by EPID Research in ESC Congress 2016, 27-31 August, 2016: – Gender differences in oral antiplatelet treatment use – results from a nationwide cohort study of acute coronary syndrome patients in Finland – Poster – Age predicts initiation of and persistence with P2Y12 inhibitor treatment […]

EPID Research presented four posters in 32nd ICPE

29.8.2016 – EPID Research presented four posters in ICPE 32nd International Conference, 25-28 August, 2016: – Contraindicated and off-label drug use in pediatric outpatients in the Nordic countries – Spotlight poster – COPD Patients Initiating Roflumilast in Sweden, Germany and the United States: Findings from the Roflumilast PASS study – Poster – The quality of warfarin therapy among atrial […]

Cardiac mortality and use of progestin for menopause study

12.5.2016 – Our new article on cardiac mortality and use of progestin for menopause has been published. Cardiac Death Risk in Relation to the Age at Initiation or the Progestin Component of Hormone Therapies. Published in Journal of Endocrinology & Metabolism, doi: 10.1210/jc.2015-4149 – Article

New article on basal insulins

31.3.2016 – Our new article on mortality and use of certain basal insulins has been published. All-cause and cause-specific mortality among users of basal insulins NPH, detemir and glargine. Published in PLoS One 2016, doi:10.1371/journal.pone.0151910 –Article

Melanoma treatment and RWD

23.11.2015 – Melinda Manley Daumont presented a poster of a study conducted by EPID Research “Comparative effectiveness research of treatments for advanced melanoma in Europe using existing real-world data sources: A feasibility assessment” in the Society for Melanoma Research 2015 International Congress, 18-21 November 2015 – Poster – Abstract